Paclip 300mg Injection
Marketer
Alpine Lifescience Private Limited
Salt Composition
Paclitaxel (6mg/ml)
Overview Paclip 300mg Injection
Oncaspar 300mg injection combats various cancers, including breast, pancreatic, and non-small-cell lung cancers. Administered intravenously by healthcare professionals, the dosage and frequency are determined individually by your physician based on your specific condition and may be adjusted. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe complications. While benefits may take weeks or months to manifest, discontinue use only under medical supervision. Common side effects include nausea, vomiting, and fatigue; serious side effects such as edema (hand/lip swelling), alopecia, and weight gain are also possible. Concomitant medications may be prescribed to mitigate these effects. Report any unusual bruising/bleeding, sore throat, mouth sores, or fever immediately. This medication can reduce blood cell counts, increasing infection risk, necessitating regular blood tests to monitor blood cell levels and liver function. Prior to treatment, disclose any existing heart, liver, or kidney conditions, and all current medications, particularly anti-infectives, as drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is essential throughout the treatment period.
Uses of Paclip 300mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas
Major Benefits of Paclip 300mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Paclip 300mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Paclip 300mg Injection:
This medication will be administered by your physician or their qualified staff; self-medication is strictly prohibited.
How Paclip 300mg Injection works:
Oncaspar 300mg Injection is a cancer treatment agent. Its mechanism of action involves disrupting microtubule assembly, a process crucial for cancer cell division and proliferation. This targeted interference inhibits tumor growth, ultimately leading to cancer cell death.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Paclip 300mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Paclip 300mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Paclip 300mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Paclip 300mg Injection might induce adverse reactions that could impair driving ability. While continued driving between treatment cycles isn't inherently prohibited, the medication's alcohol content warrants caution regarding driving.
KidneySAFE IF PRESCRIBED
Paclip 300mg Injection poses no known safety risk for individuals with kidney impairment; dosage modification is unnecessary. Nevertheless, consult your physician regarding any pre-existing renal conditions.
LiverCAUTION
Patients with liver impairment should receive Paclip 300mg Injection cautiously, potentially requiring dosage modification. Consult a physician before administration. Paclip 300mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Paclip 300mg Injection :
NA
Facts to Know About Paclip 300mg Injection
| Label | Value |
|---|---|
| Type of Compound | Taxane-based medications |
| Addictive | None. |
| Type of Medication | Cancer-fighting drugs |
| Mechanism of Action | Microtubule-targeting drugs: Taxane class |


